Companies

What will Netflix do next?

From November 2022, Netflix will introduce a cheaper ad-supported subscription option, a move that seemed improbable just a year ago.…

Lara Williams

Features

How is activity in the pharma sector recovering from Covid-19’s impact?

Features

Valence Discovery: transforming AI-enabled drug design with ‘few-shot learning’

News

Servier found guilty of deception and manslaughter over deadly weight loss pill

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Pharmaceutical Technology Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

What will Netflix do next?

How is activity in the pharma sector recovering from Covid-19’s impact?

Valence Discovery: transforming AI-enabled drug design with ‘few-shot learning’

Servier found guilty of deception and manslaughter over deadly weight loss pill

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Leading account and intent-based sales and marketing providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing